ProMIS™ Neurosciences, Inc.
Precision therapeutics for protein misfolding disorders, including Alzheimer's, ALS and Parkinson’s disease.
22 employees · est. 2015 · Cambridge, United States
ProMIS™ Neurosciences, Inc. is the older company (2015 vs 2016); QurAlis is the larger of the two.
3 signals in the last 90 days
Side-by-Side Comparison
| Metric | ProMIS™ Neurosciences, Inc. | QurAlis |
|---|---|---|
| Founded | ||
| Founded | 2015 older | 2016 |
| Headquarters | ||
| Headquarters | Cambridge, United States | Cambridge, United States |
| Employees | ||
| Employees | 22 | 89 larger |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Unknown | Unknown |
| Total Funding | ||
| Total Funding | $233.31M | $160.42M |
| Funding Rounds | ||
| Funding Rounds | 17 | 5 |
| Services | ||
| Services | Selective Antibody Therapy Development, Protein Folding Prediction, Clinical Research and Trials | Development of Precision Medicines, Research in Neurodegenerative Diseases, Advancement of Therapeutic Candidates, Proprietary Anti-Sense Oligonucleotide Platform |
| Target Customers | ||
| Target Customers | Healthcare Providers, Pharmaceutical Companies, Neuroscientific Research Institutions | Patients with ALS, Patients with Neurodegenerative Diseases, Healthcare Providers, Neurology Researchers |
| Taxonomy | ||
| Taxonomy | Neuroscience, Alzheimer's Disease, Amyotrophic Lateral Sclerosis, Multiple System Atrophy, Treatment Development, Antibody Discovery, Misfolded Proteins, Disease-modifying Treatments | Neuro Pioneers, Precision Medicine, Neurodegenerative Diseases, ALS, FTD, Innovation, Therapeutic Candidates, Genetic Mutations, Clinical Biomarkers, Harvard Medical School, Biologists, Drug Development |
| Website | ||
| Website | promisneurosciences.com | quralis.com |
About ProMIS™ Neurosciences, Inc.
ProMIS™ Neurosciences, Inc., founded in 2015 and headquartered in Canada, is a pioneering entity within the Biotechnology and Health Care sectors. The company is committed to developing next-generation, disease-modifying treatments specifically targeting Alzheimer’s disease, amyotrophic lateral scle...
About QurAlis
QurAlis, founded in 2016, is a biotechnology startup located in the United States, specializing in precision medicines for neurodegenerative diseases. Their slogan, "Neuro Pioneers on a Quest to Cure," encapsulates their mission to transform the treatment landscape for diseases like amyotrophic late...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at ProMIS™ Neurosciences, Inc. and QurAlis — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at ProMIS™ Neurosciences,... and QurAlis — by email.
Frequently Asked Questions
Compare ProMIS™ Neurosciences, Inc. with someone else
Start typing a company name or domain.